Dapagliflozin and acute heart failure
Phase 3
- Conditions
- Heart Failure.Systolic (congestive) heart failureI50.0
- Registration Number
- IRCT20150617022794N3
- Lead Sponsor
- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Acute heart failure
BNP>100 pg/ml
receiving IV furosemide
Evidence of congestion
Exclusion Criteria
Serum glucose < 80 mg/dL
Type 1 diabetes mellitus
Systolic blood pressure < 90 mmHg
Requirement of inotropic therapy
hypersensitivity to SGLT-2 inhibitors
Already receiving an SGLT2 inhibitor
Pregnancy
History of DKA
Acute MI
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method